- Home
- MOV vs CVRX Comparison
MOV vs CVRX Comparison
Compare MOV & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOV
- CVRX
- Stock Information
- Founded
- MOV 1961
- CVRX 2000
- Country
- MOV United States
- CVRX United States
- Employees
- MOV N/A
- CVRX N/A
- Industry
- MOV Consumer Specialties
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MOV Consumer Discretionary
- CVRX Health Care
- Exchange
- MOV Nasdaq
- CVRX Nasdaq
- Market Cap
- MOV 441.7M
- CVRX 419.8M
- IPO Year
- MOV 1993
- CVRX 2021
- Fundamental
- Price
- MOV $19.68
- CVRX $13.85
- Analyst Decision
- MOV Strong Buy
- CVRX Strong Buy
- Analyst Count
- MOV 2
- CVRX 7
- Target Price
- MOV $36.25
- CVRX $17.83
- AVG Volume (30 Days)
- MOV 143.5K
- CVRX 219.8K
- Earning Date
- MOV 03-25-2025
- CVRX 02-04-2025
- Dividend Yield
- MOV 7.13%
- CVRX N/A
- EPS Growth
- MOV N/A
- CVRX N/A
- EPS
- MOV 1.05
- CVRX N/A
- Revenue
- MOV $658,329,000.00
- CVRX $51,292,000.00
- Revenue This Year
- MOV N/A
- CVRX $27.21
- Revenue Next Year
- MOV $4.31
- CVRX $25.87
- P/E Ratio
- MOV $18.70
- CVRX N/A
- Revenue Growth
- MOV N/A
- CVRX 30.53
- 52 Week Low
- MOV $17.86
- CVRX $6.40
- 52 Week High
- MOV $29.14
- CVRX $22.50
- Technical
- Relative Strength Index (RSI)
- MOV 50.42
- CVRX 39.53
- Support Level
- MOV $19.36
- CVRX $14.07
- Resistance Level
- MOV $20.33
- CVRX $15.42
- Average True Range (ATR)
- MOV 0.66
- CVRX 0.88
- MACD
- MOV 0.06
- CVRX -0.23
- Stochastic Oscillator
- MOV 67.98
- CVRX 13.84
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.